Recommending Higher Valent Pneumococcal Conjugate Vaccine for Older Adults

被引：0
|
作者：
Fedson, David S. [1 ]
机构：
[1] 57 Chemin Lavoir Sergy Haut, F-01630 Ain, France
来源：
JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 06期
关键词：
IMMUNIZATION; PNEUMONIA;
D O I：
10.1001/jamainternmed.2023.0548
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [1] Recommending Higher Valent Pneumococcal Conjugate Vaccine for Older Adults-Reply
    Kobayashi, Miwako
    Pilishvili, Tamara
    Lessa, Fernanda C.
    JAMA INTERNAL MEDICINE, 2023, 183 (06) : 624 - 624
  • [2] Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): In older adults
    Sanford M.
    Drugs, 2012, 72 (9) : 1243 - 1255
  • [3] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) In Older Adults
    Sanford, Mark
    DRUGS, 2012, 72 (09) : 1243 - 1255
  • [4] Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ngamprasertchai, Thundon
    Ruenroengbun, Narisa
    Kajeekul, Rattagan
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02):
  • [5] Erratum to Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults
    M. Sanford
    Drugs, 2012, 72 : 2176 - 2176
  • [6] Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in older adults
    Hsiao, Amber
    Lewis, Ned
    Hansen, John
    Timbol, Julius
    Suaya, Jose A.
    Alexander-Parrish, Ronika
    Grant, Lindsay R.
    Gessner, Bradford D.
    Klein, Nicola P.
    VACCINE, 2025, 44
  • [7] Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea
    Kang, Dong-Won
    Kim, Chae-Rin
    Song, Joon Young
    Park, Sun-Kyeong
    VACCINE, 2024, 42 (04) : 871 - 878
  • [8] 13-valent Pneumococcal Conjugate Vaccine in Older Children and Adolescents Either Previously Immunized With or Naive to 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Senders, Shelly
    Harris-Ford, Laurie
    Sperling, Malcolm
    Patterson, Scott
    Devlin, Carmel
    Jansen, Kathrin U.
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (02) : 183 - 189
  • [9] Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
    Gourzoulidis, George
    Barmpouni, Myrto
    Kossyvaki, Vasiliki
    Vietri, Jeffrey
    Tzanetakos, Charalampos
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [10] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Jaime E Ordóñez
    John J Orozco
    BMC Infectious Diseases, 14
12345